Shijiazhuang, China

Dongjian Chen

This inventor holds 1 USPTO granted patent and 3 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Cspc Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd.. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dongjian Chen. Retrieved from https://idiyas.com/inventor/dongjian-chen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Dongjian Chen

Introduction

Dongjian Chen is a notable inventor based in Shijiazhuang, China. He has made significant contributions to the field of pharmaceutical technology, particularly in the development of therapeutic nanoparticles. His work focuses on enhancing the efficacy of drug delivery systems.

Latest Patents

Dongjian Chen holds a patent for "Purified therapeutic nanoparticles and preparation methods thereof." This patent describes nanoparticles that comprise an active pharmaceutical ingredient and human serum albumin. The weight ratio of human serum albumin to the active ingredient in these therapeutic nanoparticles ranges from 0.01:1 to 1:1. Importantly, the nanoparticles are designed to be substantially free of free human serum albumin that is not incorporated in the nanoparticles. The patent also includes pharmaceutical compositions that utilize these purified therapeutic nanoparticles, which are similarly free of free human serum albumin. Methods for preparing and using these nanoparticles and compositions are also detailed in the patent.

Career Highlights

Throughout his career, Dongjian Chen has worked with Cspc Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. and Cspc Zhongqi Pharmaceutical Technology Co., Ltd. His experience in these companies has allowed him to refine his expertise in pharmaceutical innovations.

Collaborations

Dongjian Chen has collaborated with Chunlei Li, contributing to advancements in the field of therapeutic nanoparticles.

Conclusion

Dongjian Chen's work in developing purified therapeutic nanoparticles represents a significant advancement in pharmaceutical technology. His innovative approach to drug delivery systems has the potential to improve patient outcomes and enhance the effectiveness of treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…